Precision BioSciences, Inc. (DTIL)
9.87
+1.75
(+21.55%)
USD |
NASDAQ |
Nov 05, 16:00
9.80
-0.07
(-0.71%)
After-Hours: 07:29
Precision BioSciences Price to Book Value : 5.317 for Nov. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 5.317 |
| November 04, 2026 | 4.374 |
| November 03, 2026 | 3.755 |
| November 02, 2026 | 3.744 |
| October 30, 2026 | 3.804 |
| October 29, 2026 | 4.008 |
| October 28, 2026 | 4.024 |
| October 27, 2026 | 3.658 |
| October 26, 2026 | 3.453 |
| October 23, 2026 | 3.577 |
| October 22, 2026 | 3.653 |
| October 21, 2026 | 3.615 |
| October 20, 2026 | 3.534 |
| October 19, 2026 | 3.335 |
| October 16, 2026 | 3.108 |
| October 15, 2026 | 3.324 |
| October 14, 2026 | 3.249 |
| October 13, 2026 | 3.286 |
| October 12, 2026 | 3.518 |
| October 09, 2026 | 3.620 |
| October 08, 2026 | 3.464 |
| October 07, 2026 | 3.367 |
| October 06, 2026 | 3.340 |
| October 05, 2026 | 3.399 |
| October 02, 2026 | 3.399 |
| Date | Value |
|---|---|
| October 01, 2026 | 3.410 |
| September 30, 2026 | 3.372 |
| September 29, 2026 | 3.607 |
| September 28, 2026 | 3.642 |
| September 25, 2026 | 3.630 |
| September 24, 2026 | 3.694 |
| September 23, 2026 | 3.712 |
| September 22, 2026 | 4.196 |
| September 21, 2026 | 3.794 |
| September 18, 2026 | 3.893 |
| September 17, 2026 | 3.893 |
| September 16, 2026 | 3.869 |
| September 15, 2026 | 3.858 |
| September 14, 2026 | 4.004 |
| September 11, 2026 | 4.184 |
| September 10, 2026 | 4.225 |
| September 09, 2026 | 4.231 |
| September 08, 2026 | 4.319 |
| September 04, 2026 | 4.360 |
| September 03, 2026 | 4.301 |
| September 02, 2026 | 4.348 |
| September 01, 2026 | 4.459 |
| August 31, 2026 | 4.459 |
| August 28, 2026 | 4.540 |
| August 27, 2026 | 4.902 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.35 |
| Anika Therapeutics, Inc. | 1.884 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.003 |
Price to Book Value Related Metrics
| PS Ratio | 5.319 |
| Price | 9.87 |
| Earnings Yield | -13.01% |
| Market Cap | 275.30M |